{"id":"https://openalex.org/W2027379147","doi":"https://doi.org/10.1139/y91-215","title":"Bioavailability of aspirin and salicylamide following oral co-administration in human volunteers","display_name":"Bioavailability of aspirin and salicylamide following oral co-administration in human volunteers","publication_year":1991,"publication_date":"1991-10-01","ids":{"openalex":"https://openalex.org/W2027379147","doi":"https://doi.org/10.1139/y91-215","mag":"2027379147","pmid":"https://pubmed.ncbi.nlm.nih.gov/1777842"},"language":"en","primary_location":{"id":"doi:10.1139/y91-215","doi":"https://doi.org/10.1139/y91-215","is_oa":false,"landing_page_url":"https://doi.org/10.1139/y91-215","pdf_url":null,"source":{"id":"https://openalex.org/S82722058","display_name":"Canadian Journal of Physiology and Pharmacology","issn_l":"0008-4212","issn":["0008-4212","1205-7541"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310312929","host_organization_name":"Canadian Science Publishing","host_organization_lineage":["https://openalex.org/P4310312929"],"host_organization_lineage_names":["Canadian Science Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Canadian Journal of Physiology and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112792183","display_name":"Mohamed S. Abdel\u2010Rahman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4402554120","display_name":"Rutgers New Jersey Medical School","ror":"https://ror.org/014ye1258","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4402554120"]},{"id":"https://openalex.org/I4405286694","display_name":"University of Medicine and Dentistry of New Jersey","ror":"https://ror.org/02tvvmk84","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4405286694"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohamed S. Abdel-Rahman","raw_affiliation_strings":["Department of Pharmacology and Toxicology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey 07103"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey 07103","institution_ids":["https://openalex.org/I4402554120","https://openalex.org/I4405286694"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109223540","display_name":"Alluru S. Reddi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alluru S. Reddi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111673228","display_name":"Frederick A. Curro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frederick A. Curro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034768490","display_name":"Rita M. Turkall","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rita M. Turkall","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061234837","display_name":"Abdelrazak M. Kadry","orcid":"https://orcid.org/0000-0001-8548-6131","observed_orcids":["https://orcid.org/0000-0001-8548-6131"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abdelrazak M. Kadry","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5044556801","display_name":"Julia A. Hansrote","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julia A. Hansrote","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.12943747,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"69","issue":"10","first_page":"1436","last_page":"1442"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8403000235557556,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8403000235557556,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.09669999778270721,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.014800000004470348,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/salicylamide","display_name":"salicylamide","score":1.0},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.7590000033378601},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8230000138282776},{"id":"https://openalex.org/keywords/area-under-the-curve","display_name":"area under the curve","score":0.7730000019073486},{"id":"https://openalex.org/keywords/aspirin-metabolites","display_name":"aspirin metabolites","score":0.9309999942779541},{"id":"https://openalex.org/keywords/combination-analgesics","display_name":"analgesic combination","score":0.6800000071525574}],"concepts":[{"id":"https://openalex.org/C2777611233","wikidata":"https://www.wikidata.org/wiki/Q2496906","display_name":"Salicylamide","level":2,"score":0.9925208687782288},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.9356811046600342},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.7887564301490784},{"id":"https://openalex.org/C2779252780","wikidata":"https://www.wikidata.org/wiki/Q582687","display_name":"Antipyretic","level":3,"score":0.7223935127258301},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.6705771088600159},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6664590239524841},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.6477944850921631},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5106473565101624},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26996245980262756},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11483627557754517},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011208","descriptor_name":"Powders","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012457","descriptor_name":"Salicylamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012457","descriptor_name":"Salicylamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1139/y91-215","doi":"https://doi.org/10.1139/y91-215","is_oa":false,"landing_page_url":"https://doi.org/10.1139/y91-215","pdf_url":null,"source":{"id":"https://openalex.org/S82722058","display_name":"Canadian Journal of Physiology and Pharmacology","issn_l":"0008-4212","issn":["0008-4212","1205-7541"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310312929","host_organization_name":"Canadian Science Publishing","host_organization_lineage":["https://openalex.org/P4310312929"],"host_organization_lineage_names":["Canadian Science Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Canadian Journal of Physiology and Pharmacology","raw_type":"journal-article"},{"id":"pmid:1777842","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1777842","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Canadian journal of physiology and pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W2008574207","https://openalex.org/W2069277546","https://openalex.org/W2146985915","https://openalex.org/W2156737496","https://openalex.org/W4406963759","https://openalex.org/W4406990375"],"related_works":["https://openalex.org/W2335700691","https://openalex.org/W1972899573","https://openalex.org/W2076987265","https://openalex.org/W2024849375","https://openalex.org/W2356916574","https://openalex.org/W2370182802","https://openalex.org/W2035192529","https://openalex.org/W2362130685","https://openalex.org/W2334931860","https://openalex.org/W2436794847"],"abstract_inverted_index":{"BC":[0,19,25],"powder":[1,20,26],"(I)":[2],"is":[3],"a":[4,43,53,74,127],"commercially":[5],"available":[6],"analgesic":[7],"containing":[8],"the":[9,85,88,111,140],"active":[10],"ingredients":[11],"aspirin":[12,22,41,64,95,114,152],"and":[13,24,71,81],"salicylamide.":[14],"The":[15,108],"kinetics":[16],"of":[17,39,46,56,76,151],"I,":[18,40],"minus":[21,27],"(II),":[23],"salicylamide":[28,50,130,146],"(III)":[29],"were":[30],"evaluated":[31],"in":[32,119,129],"13":[33],"volunteers.":[34],"Ten":[35],"minutes":[36],"after":[37],"administration":[38],"reached":[42,52,73],"maximum":[44],"concentration":[45,51,75,90,132],"12.9":[47],"micrograms/mL,":[48],"while":[49],"peak":[54,131],"value":[55],"3.4":[57],"micrograms/mL.":[58],"However,":[59],"when":[60,96],"III":[61,97],"was":[62,65,98,100,116,133,136],"administered,":[63],"not":[66,137],"detected":[67,138],"at":[68,79],"10":[69],"min":[70],"only":[72],"0.4":[77],"microgram/mL":[78],"2":[80],"6":[82],"h.":[83],"Furthermore,":[84],"area":[86,109],"under":[87,110],"plasma":[89,149],"versus":[91,121],"time":[92],"curve":[93,112],"for":[94,113],"administered":[99],"sixfold":[101],"less":[102],"compared":[103],"with":[104,106,125,153],"treatment":[105,124],"I.":[107],"metabolites":[115],"significantly":[117,147],"different":[118],"I":[120],"III.":[122],"After":[123],"II,":[126],"delay":[128],"observed.":[134],"Gentisamide":[135],"throughout":[139],"study.":[141],"This":[142],"study":[143],"demonstrates":[144],"that":[145],"enhances":[148],"levels":[150],"potential":[154],"therapeutic":[155],"implications.":[156]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}